Organovo Holdings Inc Stock Nyse
Equities
US68620A1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 1.5M | Sales 2023 | 370K | Capitalization | 19.08M |
---|---|---|---|---|---|
Net income 2022 | -11M | Net income 2023 | -17M | EV / Sales 2022 | 4.16 x |
Net cash position 2022 | 26.49M | Net cash position 2023 | 14.2M | EV / Sales 2023 | 13.2 x |
P/E ratio 2022 |
-2.86
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.09% |
Managers | Title | Age | Since |
---|---|---|---|
Keith Murphy
CEO | Chief Executive Officer | 52 | 06-12-31 |
Thomas Hess
DFI | Director of Finance/CFO | 60 | 21-09-30 |
Steve Kunszabo
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Stern
BRD | Director/Board Member | 60 | 12-01-31 |
Keith Murphy
CEO | Chief Executive Officer | 52 | 06-12-31 |
David Gobel
BRD | Director/Board Member | 71 | 20-09-14 |
1st Jan change | Capi. | |
---|---|---|
+1.37% | 43.84B | |
+6.91% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+7.15% | 25.53B | |
-24.28% | 18.18B | |
-3.43% | 12.29B | |
+27.48% | 12.29B | |
+7.56% | 11.15B |